3D Medicines
Significantly Narrowed Full-Year Loss, Forward-Looking Strategy
1.Revenue Continues to Grow, Losses Narrowing, Ample Cash Reserves
2.Diversified Product Portfolio, Smooth Pipeline Progress
3.Valuation and Profit Forecast
4.Risk Warning
Download
